TrialJournal of the European Academy of Dermatology and Venereology : JEADV2026

Efficacy and safety of ME3183, an oral phosphodiesterase 4 inhibitor, in patients with plaque psoriasis.

Kim A Papp et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.